Cargando…

Long-Term Predictors of Clinical Events after Off-Label Use of Drug-Eluting Stent beyond 1 Year

BACKGROUND AND OBJECTIVES: We evaluated the long-term outcomes and predictors of clinical events after off-label use of drug-eluting stents (DES) beyond 1 year after procedure. SUBJECTS AND METHODS: A total of 518 patients who underwent DES implantation for off-label indications and did not have any...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Kyeong Ho, Ko, Jum Suk, Rhee, Sang Jae, Lee, Eun Mi, Yoo, Nam Jin, Kim, Nam-Ho, Oh, Seok Kyu, Jeong, Jin-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629241/ https://www.ncbi.nlm.nih.gov/pubmed/23613692 http://dx.doi.org/10.4070/kcj.2013.43.3.161

Ejemplares similares

Left Ventricular Thrombus Associated with Takotsubo Cardiomyopathy: A Cardioembolic Cause of Cerebral Infarction
por: Shin, Seoung-Nam, et al.
Publicado: (2011)

The Number of Endothelial Progenitor Cells is Decreased in Patients With Non-Dipper Hypertension
por: Kim, Seunghwan, et al.
Publicado: (2012)

Five-year clinical outcomes of drug-eluting stents according to on-label and off-label use
por: Park, Kyu-Hwan, et al.
Publicado: (2016)

Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation
por: Choi, Hyun-Chul, et al.
Publicado: (2010)

Erratum to: Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction
por: Kim, Ji Won, et al.
Publicado: (2014)

Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction
por: Kim, Ji Won, et al.
Publicado: (2014)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis
por: Choi, Hong Sang, et al.
Publicado: (2011)

Correlations between High Platelet Reactivity, Extent of Coronary Artery Disease, and Periprocedural Myonecrosis in Patients with Acute Coronary Syndrome
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Can documented coronary vasospasm be the smoking gun in settling the etiology of sudden cardiac death?
por: Kim, Nam-Ho, et al.
Publicado: (2017)

Introduction of Wearable Device in Cardiovascular Field for Monitoring Arrhythmia
por: Kim, Nam Ho, et al.
Publicado: (2021)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

Pulmonary Artery Stents-Still "Off Label"
por: Kim, Seong-Ho
Publicado: (2012)

Zotarolimus-eluting stent-induced hypersensitivity pneumonitis
por: Shin, Hong-Won, et al.
Publicado: (2013)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)
por: Kim, Yongcheol, et al.
Publicado: (2019)

Efficacy of Triple Anti-Platelet Therapy Including Cilostazol in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stent Implantation
por: Park, Keun-Ho, et al.
Publicado: (2009)

Clinical Impact of Lesion Complexity on 2-Year Outcomes After Zotarolimus-Eluting Stents Implantation
por: Park, Jung-Ho, et al.
Publicado: (2021)

Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Chun, Kyeong-Hyeon, et al.
Publicado: (2017)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Clinical Significance of On-Treatment Triglyceride Level in Patients Treated by Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome
por: Yun, Kyeong Ho, et al.
Publicado: (2009)

Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial
por: Chae, In-Ho, et al.
Publicado: (2017)

Protective Effect of Cilostazol Against Restraint Stress Induced Heart Failure in Post-Myocardial Infarction Rat Model
por: Lee, Moon Young, et al.
Publicado: (2020)

Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2015)

Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention
por: Cho, Yun-Kyeong, et al.
Publicado: (2014)

Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
por: Cho, Yun-Kyeong, et al.
Publicado: (2014)

Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study
por: Cho, Yun-Kyeong, et al.
Publicado: (2009)

Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Song, Pil Sang, et al.
Publicado: (2018)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
por: Choi, Wonsuk, et al.
Publicado: (2019)

Predictors of diffuse-type in-stent restenosis following drug-eluting stent implantation
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
por: Condello, Francesco, et al.
Publicado: (2023)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
por: Zheng, Chengbin, et al.
Publicado: (2019)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model
por: Kwon, Jin Sook, et al.
Publicado: (2011)

Antibiotic eluting sinus stents
por: Thompson, Harrison M., et al.
Publicado: (2020)

Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
por: Tantawy, Ayman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q7pvhq9eog0a9tj1cv6q3v1830